Hemp Inc. is showing promising product sales number claiming to hit $16.2 billion by 2033.
Hemp Inc. released numbers in July 2023, showcasing that global market hemp-based product sales are expected to reach $16.2 billion by 2033 (1). Hemp-based products are currently valued at $1.8 billion, according to Fact.MR (2), and will continue to rise over the next 10 years due to less restraints, shifting trends, more opportunities, and increased drivers. This recent data shows segments and sub-segments in the hemp industry and looks at terms of value and volume. According to Fact.MR, it ““elaborates market behavior of each vendor operating in the hemp-based products market,” (3).
Executives of Hemp Inc. are hopeful that their e-portal to their cannabidiol (CBD) products “will capture a large share of the marketplace,” (1) if the hemp industry keeps on evolving. A report from Transparency Market Research, Inc. (4), highlighted that there was an “inclination of the younger population toward organic and natural products is anticipated to drive the demand for hemp-based products globally.” Hemp Inc., has a large lineup of other cannabinoid products such as their CBD lineup but as well as with their cannabigerol (CBG) and cannabinol (CBN) products. The company lists some of their products: a CBD-CBG Topical Pain Relief Roll-on, CBD/CBG Natural Coffee Enhancers, CBD/CBG Tinctures, and cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), CBD, CBG, CBN Capsules. The report mentioned as well, “restrictions on export and import of hemp seeds and hemp-based products in a number of countries are likely to impede market development in the next few years,” (1,4). To address this issue (1,4), “firms in the global hemp-based products market are concentrating on expanding their geographic reach through tactical acquisitions and partnerships with key players in their respective region. A slew of international firms possessing strong R&D capabilities and skills and online platforms are likely to enter the domain of hemp-based products to grab as much of the global market share as possible.”
Hemp Inc. has a firm grip in the hemp market. The company also has manufacturers and vendors across the US and abroad to help keep up the demand of their products. With these options available, they are able to produce and/or provide raw materials to create hemp-based products such as, hempcrete, hemp bio-plastics, horse bedding, and more (1). Hemp Inc. recently found out that their kenaf hemp blend can be used as a substrate to grow healthy or medicinal mushrooms. Through the various uses of hemp, it shows that the industry has a lot of room for growth.
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.